Pfizer financials at a glance

Year Year 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2021 2022 2023 2024
Rev. Revenue
$41.65B $40.91B $40.83B $52.55B $52.82B $48.85B $49.61B $51.58B $54.66B $61.04B $65.17B $49.27B $48.30B $48.42B $48.37B $47.41B $48.99B $81.29B $100.33B $58.50B $0.00M
GM % Gross Margin %
79.91% 80.82% 78.27% 79.40% 77.44% 80.84% 81.79% 82.07% 82.63% 80.83% 78.43% 83.19% 84.75% 83.60% 85.02% 85.01% 86.95% 62.28% 66.02% 58.99% 0.00%
OM Operating Margin
23.17% 19.90% 18.02% 28.00% 26.69% 28.23% 31.58% 32.99% 33.54% 30.12% 26.96% 32.15% 34.42% 30.09% 31.20% 30.65% 33.53% 33.02% 38.87% 8.99% 0.00%
EPS Earnings Per Share
$2.02 $2.06 $2.20 $2.41 $2.02 $2.23 $2.31 $2.19 $2.22 $2.26 $2.20 $2.40 $2.65 $3.00 $2.95 $2.22 $4.42 $6.58 $1.84 $0.00
Div. Dividends
$1.52 $1.44 $1.36 $1.28 $1.20 $1.12 $1.04 $0.96 $0.88 $0.80 $0.72 $0.80 $1.28 $1.16 $0.96 $0.76 $0.70 $1.56 $1.61 $1.66 $0.00
PR % Payout Ratio %
68.47% 48.81% 45.33% 48.30% 50.00% 50.91% 46.02% 43.24% 40.18% 34.63% 32.29% 39.60% 53.11% 52.73% 46.60% 37.62% 33.02% 35.29% 24.47% 90.22% 0
Sha. Shares
5558.4m 5534.12m 5780.47m 5960.71m 6068.36m 6173.5m 6300.66m 6481.07m 7362.57m 7686.97m 8009.95m 8069.54m 6,740m 6829.81m 7210.44m 7371.4m 7,531m 5612.87m 5610.9m 5646.41m 5646.41m
OCF Operating Cash Flow
$14.40B $12.59B $15.83B $16.80B $16.19B $14.69B $17.08B $17.68B $16.75B $20.24B $11.45B $16.59B $18.24B $13.35B $17.59B $14.73B $16.34B $32.58B $29.27B $0.00M $0.00M
FCF Free Cash Flow
$12.15B $10.41B $13.79B $14.51B $14.08B $13.12B $15.68B $16.56B $15.73B $18.58B $9.94B $15.38B $16.54B $11.47B $15.54B $12.63B $13.74B $29.87B $26.03B $10.86B $0.00M
FCFS Free Cash Flow Per Share
$2.19 $1.89 $2.33 $2.44 $2.33 $2.14 $2.44 $2.38 $2.06 $2.35 $1.24 $2.20 $2.46 $1.66 $2.15 $1.72 $1.82 $5.33 $4.64 $0.00 $0.00